Genomatica raises Series C

California synthetic biology (synbio) start-up Genomatica recently announced the close of its $15 million Series C round of financing, including TPG Biotech, Mohr Davidow Ventures, Alloy Ventures, and Draper Fisher Jurvetson as investors. With the current round, the firm has accumulated over $35 mil...

This item has been archived in line with our efforts to keep our content relevant and up to date for our readership. For further assistance, please contact your Customer Success Manager or email Thank you!

Related Research

Microphyt to build new microalgae biorefinery following €15 million grant

News Commentary | July 08, 2021

The Bio‑Based Industries Joint Undertaking (BBI JU) has granted €15 million in funding to French company Microphyt (Lux Take: Engage) through the SCALE project. This four‑year project, spearheaded by Microphyt, will bring together 11 industrial partners and enable the construction of a microalgae ... Not part of subscription


Company Profile | April 19, 2022

Uses dynamic metabolic control to optimize high‑margin microbial products including flavors and fragrances, nutraceuticals, natural products, active pharmaceutical ingredients, and amino acids Claims its technology is a quicker and more efficient than brute force methods employed by dominant ... Not part of subscription

P2 Science

Company Profile | May 17, 2022

Developed an ozonolysis platform to convert vegetable oils and other biobased feedstocks into diacids, aldehydes, and other oxidation products; primarily uses high‑oleic oils like palm oil and soybean oil as feedstock Continuous small‑volume process reduces the potential danger associated with ... Not part of subscription